To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Organon is a pharmaceutical company headquartered in Oss, Netherlands that is part of Akzo Nobel.
Additional recommended knowledge
Organon deals in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, HRT and anesthesia. Organon sells to international markets.
Organon was founded by Dr. Saal van Zwanenberg in Oss, the Netherlands, in 1923 as Zwanenberg-Organon. Its first product was insulin. In the thirties it manufactured estrogens. The production of cortison was initiated in 1953. The now named Koninklijke Zwanenberg-Organon (KZO) fused with the fiber producer AKU in 1969 to become AKZO, later Akzo Nobel. Organon is the human health care business unit of Akzo Nobel and transferred its headquarters to the USA while the main headquarter of Akzo Nobel remains in Arnhem. Manufacturing facilities are in the Netherlands, Germany, the United Kingdom, China, Japan, and the USA.
On March 12, 2007, Schering Plough announced its intention to acquire Organon BioSciences for € 11 billion. During the course of several months the necessary approvals have been granted by the EU (amongst others). Organon is now a part of the Schering Plough corp.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Organon_International". A list of authors is available in Wikipedia.|